PISCUOGLIO, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 3.529
NA - Nord America 2.901
SA - Sud America 694
EU - Europa 483
AF - Africa 77
OC - Oceania 6
Totale 7.690
Nazione #
US - Stati Uniti d'America 2.787
SG - Singapore 2.144
CN - Cina 605
BR - Brasile 561
VN - Vietnam 335
HK - Hong Kong 163
IT - Italia 135
IN - India 55
DE - Germania 53
GB - Regno Unito 52
AR - Argentina 49
MX - Messico 45
CA - Canada 41
RU - Federazione Russa 35
BD - Bangladesh 34
FI - Finlandia 34
FR - Francia 34
EC - Ecuador 27
IQ - Iraq 27
PL - Polonia 20
VE - Venezuela 19
NL - Olanda 18
TR - Turchia 18
UZ - Uzbekistan 16
ZA - Sudafrica 16
ID - Indonesia 15
MY - Malesia 15
ES - Italia 13
JP - Giappone 13
KE - Kenya 13
SA - Arabia Saudita 13
NG - Nigeria 12
SE - Svezia 12
CL - Cile 11
IE - Irlanda 11
MA - Marocco 11
PK - Pakistan 10
PY - Paraguay 10
UA - Ucraina 10
CO - Colombia 9
PH - Filippine 8
CR - Costa Rica 7
KG - Kirghizistan 7
CZ - Repubblica Ceca 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AT - Austria 5
AU - Australia 5
AZ - Azerbaigian 5
EG - Egitto 5
HN - Honduras 5
LT - Lituania 5
NP - Nepal 5
AM - Armenia 4
BE - Belgio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
RO - Romania 4
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
IR - Iran 3
LV - Lettonia 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
LU - Lussemburgo 2
MG - Madagascar 2
NI - Nicaragua 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 7.679
Città #
Singapore 830
San Jose 550
Ashburn 506
The Dalles 325
Shanghai 225
Beijing 188
New York 172
Dallas 163
Hong Kong 156
Ho Chi Minh City 120
Hanoi 80
Los Angeles 78
Wilmington 56
Santa Clara 54
Chandler 52
São Paulo 52
Boardman 44
Buffalo 44
Milan 42
Helsinki 33
San Mateo 32
Mexico City 22
Haiphong 19
Orem 19
Seattle 18
Brooklyn 17
Warsaw 17
Da Nang 16
Tashkent 16
Belo Horizonte 14
Chennai 14
Chicago 14
Frankfurt am Main 14
Naples 14
Boston 13
Phoenix 13
Rio de Janeiro 13
Tokyo 13
Atlanta 12
Lawrence 12
Munich 12
Paris 12
Princeton 12
Council Bluffs 11
Dublin 11
Johannesburg 11
Toronto 11
Benin City 10
London 10
Moscow 10
Nairobi 10
San Francisco 10
Biên Hòa 9
Fairfield 9
Guayaquil 9
Manchester 9
Montreal 9
Abbiategrasso 8
Ankara 8
Assago 8
Baghdad 8
Brasília 8
Campinas 8
Dhaka 8
Goiânia 8
Kuala Lumpur 8
Mumbai 8
Amsterdam 7
Bishkek 7
Buenos Aires 7
Fortaleza 7
Guarulhos 7
San José 7
Stockholm 7
Curitiba 6
Denver 6
Houston 6
Hải Dương 6
Porto Alegre 6
Quito 6
Ann Arbor 5
Brno 5
Bắc Giang 5
Charlotte 5
Erbil 5
Hillsboro 5
Joinville 5
Recife 5
Ribeirão Preto 5
Riyadh 5
Salvador 5
Santiago 5
Sydney 5
Acalanes Ridge 4
Amman 4
Araçatuba 4
Baku 4
Brussels 4
Caracas 4
Istanbul 4
Totale 4.525
Nome #
SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules 188
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition 101
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 97
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. 93
PS-24-008 Prevalence of vessels encapsulating tumour clusters (VETC) in human cancers 92
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 84
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 72
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 72
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 72
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle 71
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 70
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal can-cer. 69
Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients 68
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 68
Arginine reprograms metabolism in liver cancer via RBM39 67
Skeletal Muscle Disorders: A Non-cardiac Source of Cardiac Troponin T 66
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 63
In vivo interaction screening reveals liver-derived constraints to metastasis 62
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 61
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer 61
Genomic landscape of adenoid cystic carcinoma of the breast 60
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 60
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study 60
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients 60
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 59
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 58
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 58
Breast cancer intra-tumor heterogeneity 57
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas 56
Variant Calling Methods and Protocols 56
The Genomic Landscape of Male Breast Cancers 56
The protein histidine phosphatase LHPP is a tumour suppressor 55
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 54
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis 54
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 54
Genomic characterization of metastatic breast cancers 53
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 53
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle (vol 25, pg 1729, 2014) 53
3 '-UTR Poly(T/U) Tract Deletions and Altered Expression of EWSR1 Are a Hallmark of Mismatch Repair-Deficient Cancers 53
A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth 53
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 52
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 52
Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma 52
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer 51
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors 51
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 51
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 50
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 50
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 50
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 50
Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells 49
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 49
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 49
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 49
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 49
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity 49
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 49
Patient-derived xenografts and organoids model therapy response in prostate cancer 49
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 49
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 48
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 48
A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer 47
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 47
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 46
Minor intron splicing is critical for survival of lethal prostate cancer 46
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 46
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 46
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 46
ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation 45
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 45
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 45
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 45
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 45
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 45
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy 45
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 45
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 45
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 44
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 44
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 44
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 44
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 44
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 44
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 44
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 44
Fragment-sequencing unveils local tissue microenvironments at single-cell resolution 43
Survivin Expression in Renal Cell Carcinoma 43
Contralateral breast cancers: Independent cancers or metastases? 43
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 43
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 42
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 42
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 42
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 42
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids 42
Uterine adenosarcomas are mesenchymal neoplasms 41
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 41
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 41
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 41
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma 41
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers 40
Totale 5.473
Categoria #
all - tutte 45.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/202256 1 0 1 16 0 0 1 12 2 1 12 10
2022/2023146 26 10 26 10 11 9 1 15 19 16 3 0
2023/2024671 1 12 16 4 5 215 31 38 30 39 111 169
2024/20251.899 33 8 9 41 16 249 108 104 323 469 273 266
2025/20265.004 713 430 219 490 116 255 1.380 270 204 390 343 194
Totale 7.875